Idiopathic pulmonary fibrosis in west highland white terriers

Veterinary Clinics of North America - Small Animal Practice

Volumn 44, Issue 1, 2014, Pages 129-142

  Heikkilä Laurila, Henna P ^a   Rajamäki, Minna M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Arterial blood gases; Biomarker; Bronchoalveolar lavage; Dog; HRCT; Interstitial lung disease

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; BIOLOGICAL MARKER; CORTICOSTEROID; ENDOTHELIN 1; HISTAMINE H2 RECEPTOR ANTAGONIST; PIRFENIDONE; PREDNISONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTON PUMP INHIBITOR; SILDENAFIL;

ARTERIAL OXYGEN SATURATION; BRONCHOSCOPY; CARDIOMEGALY; CAUSAL ATTRIBUTION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DOG; DOG DISEASE; DRUG EFFICACY; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; LUNG BIOPSY; LUNG LAVAGE; NONHUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; SYMPTOM; THORAX RADIOGRAPHY; WEST HIGHLAND WHITE TERRIER;

CANIS FAMILIARIS;

ARTERIAL BLOOD GASES; BIOMARKER; BRONCHOALVEOLAR LAVAGE; DOG; HRCT; INTERSTITIAL LUNG DISEASE;

ANIMALS; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; IDIOPATHIC PULMONARY FIBROSIS;

EID: 84888206475     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2013.08.003     Document Type: Review

References (53)

1. Raghu G., Collard H.R., Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824.
2. Liebow A.A. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975, 8(1):21-31.
3. Cohn L.A., Norris C.R., Hawkins E.C., et al. Identification and characterization of an idiopathic pulmonary fibrosis-like condition in cats. JVet Intern Med 2004, 18(5):632-641.
4. Williams K., Malarkey D., Cohn L., et al. Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect. Chest 2004, 125(6):2278-2288.
5. Corcoran B.M., Cobb M., Martin M.W., et al. Chronic pulmonary disease in West Highland white terriers. Vet Rec 1999, 144(22):611-616.
6. Lobetti R.G., Milner R., Lane E. Chronic idiopathic pulmonary fibrosis in five dogs. JAm Anim Hosp Assoc 2001, 37(2):119-127.
7. Norris A.J., Naydan D.K., Wilson D.W. Interstitial lung disease in West Highland White Terriers. Vet Pathol 2005, 42(1):35-41.
8. Heikkilä H.P., Lappalainen A.K., Day M.J., et al. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland white terriers with idiopathic pulmonary fibrosis. JVet Intern Med 2011, 25(3):433-439.
9. Corcoran B.M., Dukes-McEwan J., Rhind S., et al. Idiopathic pulmonary fibrosis in a Staffordshire bull terrier with hypothyroidism. JSmall Anim Pract 1999, 40(4):185-188.
10. Syrjä P., Heikkilä H.P., Rönty M., et al. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both nonspecific interstitial pneumonia and usual interstitial pneumonia in man. JComp Pathol 2013, 149:303-313.
11. Johnson V.S., Corcoran B.M., Wotton P.R., et al. Thoracic high-resolution computed tomographic findings in dogs with canine idiopathic pulmonary fibrosis. JSmall Anim Pract 2005, 46(8):381-388.
12. Schober K.E., Baade H. Doppler echocardiographic prediction of pulmonary hypertension in West Highland white terriers with chronic pulmonary disease. JVet Intern Med 2006, 20(4):912-920.
13. Erikson M., von Euler H., Ekman E., et al. Surfactant protein C in canine pulmonary fibrosis. JVet Intern Med 2009, 23:1170-1174.
14. Krafft E., Heikkilä H., Jespers P., et al. Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis. JVet Intern Med 2011, 25:990-996.
15. Heikkilä H.P., Krafft E., Jespers P., et al. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy. Vet J 2013, 196:52-56.
16. Lilja-Maula L.I., Palviainen M.J., Heikkilä H.P., et al. Proteomic analysis of bronchoalveolar lavage fluid samples obtained from West Highland White Terriers with idiopathic pulmonary fibrosis, dogs with chronic bronchitis, and healthy dogs. Am J Vet Res 2013, 74(1):148-154.
17. Cushley M., Davison A., du Bois R., et al. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999, 54:S1-S30.
18. Reinero C.R., Cohn L.A. Interstitial lung diseases. Vet Clin North Am Small Anim Pract 2007, 37(5):937-947.
19. American Thoracic Society, European Respiratory Society American Thoracic Society, European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165(2):277-304.
20. García-Sancho C., Buendía-Roldán I., Fernández-Plata M.R., et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med 2011, 105(12):1902-1907.
21. Taskar V.S., Coultas D.B. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 2006, 3(4):293-298.
22. Baumgartner K.B., Samet J.M., Stidley C.A., et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997, 155(1):242-248.
23. Gribbin J., Hubbard R., Smith C. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 2009, 103(6):927-931.
24. Tang Y.W., Johnson J.E., Browning P.J., et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. JClin Microbiol 2003, 41(6):2633-2640.
25. Calabrese F., Kipar A., Lunardi F., et al. Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis. PLoS One 2013, 8(2):e55715.
26. Kottmann R.M., Hogan C.H., Phipps R.P., et al. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 2009, 14:917-933.
27. Harari S., Caminati A. IPF: new insight on pathogenesis and treatment. Allergy 2010, 65(5):537-553.
28. Loomis-King H., Flaherty K.R., Moore B.B. Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis. Curr Opin Pharmacol 2013, 13(3):377-385.
29. Fingerlin T.E., Murphy E., Zhang W., et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013, 45:613-620.
30. Seibold M.A., Wise A.L., Speer M.C., et al. Acommon MUC5B promoter polymorphism and pulmonary fibrosis. NEngl J Med 2011, 364(16):1503-1512.
31. Webb J.A., Armstrong J. Chronic idiopathic pulmonary fibrosis in a West Highland white terrier. Can Vet J 2002, 43(9):703-705.
32. Corcoran B.M., King L.G., Schwarz T., et al. Further characterisation of the clinical features of chronic pulmonary disease in West Highland white terriers. Vet Rec 2011, 168:355.
33. Aubry M.C., Myers J.L., Douglas W.W., et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002, 77(8):763-770.
34. Selman M., Carrillo G., Estrada A., et al. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One 2007, 2(5):e482-e486.
35. Day T.K. Blood gas analysis. Vet Clin North Am Small Anim Pract 2002, 32(5):1031-1048.
36. Haskins S.C. Interpretation of blood gas measurements. Textbook of respiratory disease in dogs and cats 2004, 181-193. Saunders Elsevier, StLouis (MO). L.G. King (Ed.).
37. Erbes R., Schaberg T., Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Chest 1997, 111(1):51-57.
38. Campbell F.E. Cardiac effects of pulmonary disease. Vet Clin North Am Small Anim Pract 2007, 37(5):949-962.
39. Smith J.S., Gorbett D., Mueller J., et al. Pulmonary hypertension and idiopathic pulmonary fibrosis-a dastardly duo. Am J Med Sci 2013, 346:221-225.
40. Frankel S.K., Schwarz M.I. Update in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2009, 15(5):463-469.
41. Mercier E., Bolognin M., Hoffmann A.C., et al. Influence of age on bronchoscopic findings in healthy beagle dogs. Vet J 2011, 187:225-228.
42. Collard H.R., Loyd J.E., King T.E., et al. Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med 2007, 101(9):2011.
43. Meyer K.C., Raghu G., Baughman R.P., et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012, 185(9):1004-1014.
44. Rafii R., Juarez M.M., Albertson T.E., et al. Areview of current and novel therapies for idiopathic pulmonary fibrosis. JThorac Dis 2013, 5(1):48-73.
45. Raghu G., Anstrom K.J., King T.E., et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. NEngl J Med 2012, 366(21):1968-1977.
46. Bruss M.L., Margolin S.B., Giri S.N. Pharmacokinetics of orally administered pirfenidone in male and female beagles. JVet Pharmacol Ther 2004, 27(5):361-367.
47. Adamali H.I., Maher T.M. Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Devel Ther 2012, 6:261-271.
48. Kuehn N.F. Chronic bronchitis in dogs. Textbook of respiratory disease in dogs and cats 2004, 379-387. Saunders, St Louis (MO). L.G. King (Ed.).
49. Plumb D.C. Plumb's veterinary drug handbook 2011, Wiley-Blackwell, Ames (IA). 7th edition.
50. Kellum H.B., Stepien R.L. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. JVet Intern Med 2007, 21(6):1258-1264.
51. Brown A.J., Davison E., Sleeper M.M. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. JVet Intern Med 2010, 24(4):850-854.
52. Raghu G., Freudenberger T., Yang S., et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006, 27(1):136-142.
53. Louhelainen N., Myllärniemi M., Rahman I., et al. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis 2008, 3(4):585-602.